The European Commission is working on signing further contracts with drug companies to secure COVID-19 vaccines, German Chancellor Angela Merkel said on Friday, Trend reports with reference to Reuters.
On Thursday a spokesman had said that the European Commission has made a 336 million euro ($399.5 million) downpayment to British drug maker AstraZeneca to secure at least 300 million doses of its potential COVID-19 vaccine.
“Further such contracts are in the works,” Merkel told journalists at a news conference.